341 related articles for article (PubMed ID: 10388997)
1. Glycemic control and CAD risk: a heretical thought.
Orchard TJ
Diabetes Care; 1999 Jul; 22(7):1220. PubMed ID: 10388997
[No Abstract] [Full Text] [Related]
2. [Near-norm blood sugar regulation in diabetes. Myocardial infarct rate halved].
MMW Fortschr Med; 2005 Sep; 147(35-36):4-5. PubMed ID: 16180560
[No Abstract] [Full Text] [Related]
3. [Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].
Lambiel J; Fumeaux T
Rev Med Suisse; 2008 Aug; 4(166):1734. PubMed ID: 18777740
[No Abstract] [Full Text] [Related]
4. Cardiovascular disease (CVD) limbo: how soon and low should we go to prevent CVD in diabetes?
Maahs DM
Diabetes Technol Ther; 2012 Jun; 14(6):449-52. PubMed ID: 22472062
[No Abstract] [Full Text] [Related]
5. Hyperglycemia and cardiovascular risk in NIDDM.
Uusitupa MI; Niskanen LK
Diabetes Care; 1995 Jun; 18(6):884-5. PubMed ID: 7555522
[No Abstract] [Full Text] [Related]
6. [Intensive glucose control in type 2 diabetes is beneficial].
Nilsson PM; Attvall S
Lakartidningen; 2009 Sep 2-8; 106(36):2198. PubMed ID: 19817174
[No Abstract] [Full Text] [Related]
7. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
[No Abstract] [Full Text] [Related]
8. Blood glucose control and microvascular complications--what do we do now?
Dahl-Jørgensen K; Brinchmann-Hansen O; Bangstad HJ; Hanssen KF
Diabetologia; 1994 Dec; 37(12):1172-7. PubMed ID: 7895945
[No Abstract] [Full Text] [Related]
9. Summaries for patients. The relationship between blood sugar control and cardiovascular disease in patients with diabetes.
Ann Intern Med; 2004 Sep; 141(6):I21. PubMed ID: 15381537
[No Abstract] [Full Text] [Related]
10. Post-prandial hyperglycaemia and vascular disease.
Hanefeld M
Int J Clin Pract Suppl; 2000 Sep; (112):13-8. PubMed ID: 11064946
[No Abstract] [Full Text] [Related]
11. Glycemic variability in the development of cardiovascular complications in diabetes.
Nusca A; Tuccinardi D; Albano M; Cavallaro C; Ricottini E; Manfrini S; Pozzilli P; Di Sciascio G
Diabetes Metab Res Rev; 2018 Nov; 34(8):e3047. PubMed ID: 30028067
[TBL] [Abstract][Full Text] [Related]
12. Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus.
Koga M; Murai J; Morita S; Saito H; Kasayama S
J Diabetes Complications; 2013; 27(3):211-3. PubMed ID: 23312788
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.
Aso Y; Inukai T; Tayama K; Takemura Y
Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933
[TBL] [Abstract][Full Text] [Related]
14. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
Cavalot F
Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
[TBL] [Abstract][Full Text] [Related]
15. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M
Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
[TBL] [Abstract][Full Text] [Related]
16. Glycemic variability and diabetes retinopathy: a missing link.
Hsu CR; Chen YT; Sheu WH
J Diabetes Complications; 2015 Mar; 29(2):302-6. PubMed ID: 25534877
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Safety of Current and Emerging Glucose-Lowering Therapies.
Fitchett D
Can J Diabetes; 2015 Dec; 39 Suppl 5():S176-82. PubMed ID: 26654861
[No Abstract] [Full Text] [Related]
18. [Hypoglycemia: danger to life of diabetic patients. Higher price for blood sugar adjustment].
Füessl HS
MMW Fortschr Med; 2005 Aug; 147(31-32):4-6, 8. PubMed ID: 16128187
[No Abstract] [Full Text] [Related]
19. Clinical significance, pathogenesis, and management of postprandial hyperglycemia.
Gerich JE
Arch Intern Med; 2003 Jun; 163(11):1306-16. PubMed ID: 12796066
[TBL] [Abstract][Full Text] [Related]
20. Symposium on treatment of diabetic complications. 5. Strict glycemic control and diabetic microvascular complications.
Shichiri M
Intern Med; 1997 Feb; 36(2):144-7. PubMed ID: 9099605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
